Die Erfindung betrifft die Verwendung von Hydroxyflavone der Formel (I) oder deren Salze, als Appetitanreger, vorzugsweise in oral konsumierbaren Produkten, welche ausgewählt sind aus der Gruppe bestehend aus Lebensmitteln (insbesondere flüssige oder feste, einschließlich Halbfertigwaren), Futtermitteln und Arzneimitteln (pharmazeutische Zubereitungen).

The invention relates to yogurt dessert piece products (a product line) of solid consistency, made on the base of fresh yogurt cheese, coated with chocolate or cocoa-flavoured coating, with live bacterial flora, of rectangular design, the main component of which is fresh yogurt cheese with live bacterial flora, of solid consistency, obtained from milk or milk recombined from milk powder with water to a thicker consistency than milk, or milk concentrated by ultra-filtering or milk concentrated with milk powder; its curdling by a yogurt culture, occasionally its supplementary acidic treatment; the cutting of the curd, its solidification by heating, and the

The subject-matter is that milk and dairy products, such as treated milk, treated creams (such as treated cream, whipping cream, pressure packed cream, whipped cream), modified milks and modified dairy products, flavoured milk and flavoured liquid dairy products, fermented products - fermented milk products (such as yogurts, acidophilus milk, kefir, kefir milk, yogurt containing alternative culture, concentrated fermented milk, dairy products enriched with added dairy cultures, fermented products thermally treated after fermentation process), condensed dairy products, dried milk, milk proteins including caseinates, cheese (such as non-ripening cheese including fresh cheese, ripening cheese, blue cheese, steamed cheese, whey cheese, curdled cheese, barrelled cheese, bryndza (sheep's milk cheese), cheese products, processed cheese, processed cheese products, milk for making cheese), butter and other milk fats, buttermilk contain 0.01 to 45 vol% of colostrum referring to the whole mixture. Cow's, goat's, sheep's, buffalo's or mare's milk or mixture thereof can be used for production of the said products.

The present invention relates to a compound of formula (I), provided that this compound is not caffeine, for use in the treatment of myotonic dystrophy type 1 and type 2. The present invention also relates to compositions comprising the compound of formula (I) as defined herein. The present invention further relates to new compounds which are dimers of compounds of formula (I).